The Russian Direct Investment Fund (RDIF), and Stelis Biopharma, the biopharma division of Strides, have partnered to produce, and supply a minimum of 200 million doses of the Russian Sputnik V vaccine against coronavirus sufficient to vaccinate 100 ...